Lung Cancer Breakthrough: Gene Therapy Shows Promise

Lung cancer breakthrough? Genprex stock jumps as Reqorsa gene therapy shrinks tumors by 79% in preclinical trials, outperforming standard treatments. The secret? Reqorsa reactivates a silenced tumor suppressor gene using a novel, virus-free delivery system. Get ready for a potential game-changer in the fight against ALK-positive non-small cell lung cancer, with full data dropping at a major cancer conference this October.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.